NWBO - Northwest Biotherapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 585.85M
Enterprise Value 398.28M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)228.93
Price/Book (mrq)N/A
Enterprise Value/Revenue 3262.08
Enterprise Value/EBITDA 6-1.70

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-15,453.33%

Management Effectiveness

Return on Assets (ttm)-73.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)375k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-6.90%
Gross Profit (ttm)336k
EBITDA -57.76M
Net Income Avi to Common (ttm)-76.85M
Diluted EPS (ttm)-0.3940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.05M
Total Cash Per Share (mrq)0
Total Debt (mrq)27M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.03
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-35.8M
Levered Free Cash Flow (ttm)-4.34M

Trading Information

Stock Price History

Beta 2.46
52-Week Change 334.69%
S&P500 52-Week Change 313.11%
52 Week High 30.4000
52 Week Low 30.1400
50-Day Moving Average 30.2226
200-Day Moving Average 30.2667

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 31.15M
Shares Outstanding 5422.7M
Float 288.43M
% Held by Insiders 14.06%
% Held by Institutions 113.28%
Shares Short 314.14M
Short Ratio 313.54
Short % of Float 315.09%
Shares Short (prior month) 313.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/16
Last Split Date 3Sep 26, 2012